References
- Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 6(10), 789–802 (2006).
- Staker BL, Hjerrild K, Feese MD, Behnke CA, Burgin AB Jr, Stewart L. The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc. Natl Acad. Sci. USA 99(24), 15387–15392 (2002).
- Pourquier P, Pilon AA, Kohlhagen G, Mazumder A, Sharma A, Pommier Y. Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects. J. Biol. Chem. 272(42), 26441–26447 (1997).
- Barthelmes HU, Habermeyer M, Christensen MO et al. TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II. J. Biol. Chem. 279(53), 55618–55625 (2004).
- Perego P, Cossa G, Tinelli S et al. Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibition. Biochem. Pharmacol. 83(1), 27–36 (2012).
- Postma C, Koopman M, Buffart TE et al. DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. Ann. Oncol. 20(6), 1048–1056 (2009).
- Seo EH, Kang J, Kim KH et al. Detection of expressed IL-32 in human stomach cancer using ELISA and immunostaining. J. Microbiol. Biotechnol. 18(9), 1606–1612 (2008).
- Rogerson TE, Chen S, Kok J et al. Tests for latent tuberculosis in people with ESRD: a systematic review. Am. J. Kidney Dis. 61(1), 33–43 (2013).
- Skrzypski M. Quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR) in translational oncology: lung cancer perspective. Lung Cancer 59(2), 147–154 (2008).
- Larsson O, Tian B, Sonenberg N. Toward a genome-wide landscape of translational control. Cold Spring Harb. Perspect. Biol. 5(1) (2013).
- Bandyopadhyay K, Li P, Gjerset RA. CK2-Mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity. PLoS ONE 7(11), e50427 (2012).
- Komander D, Rape M. The ubiquitin code. Annu. Rev. Biochem. 81, 203–229 (2012).
- Das BB, Antony S, Gupta S et al. Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK. EMBO J. 28(23), 3667–3680 (2009).
- Samuels DS, Shimizu Y, Shimizu N. Protein kinase C phosphorylates DNA topoisomerase I. FEBS Lett. 259(1), 57–60 (1989).
- Knudsen BR, Jepsen ML, Ho Y-P. Quantum dot-based nanosensors for diagnosis via enzyme activity measurement. Expert Rev. Mol. Diagn. 13(4), 367–375 (2013).
- Stougaard M, Lohmann JS, Mancino A et al. Single-molecule detection of human topoisomerase I cleavage-ligation activity. ACS Nano 3(1), 223–233 (2009).
- Andersen FF, Stougaard M, Jorgensen HL et al. Multiplexed detection of site specific recombinase and DNA topoisomerase activities at the single molecule level. ACS Nano 3(12), 4043–4054 (2009).
- Jensen PW, Falconi M, Kristoffersen EL et al. Real-time detection of TDP1 activity using a fluorophore-quencher coupled DNA-biosensor. Biosens. Bioelectron. 48, 230–237 (2013).
- Marcussen LB, Jepsen ML, Kristoffersen EL et al. DNA-based sensor for real-time measurement of the enzymatic activity of human topoisomerase I. Sensors 13(4), 4017–4028 (2013).
- Juul S, Ho YP, Koch J et al. Detection of single enzymatic events in rare or single cells using microfluidics. ACS Nano 5(10), 8305–8310 (2011).